Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma

Pretreatment LMR appears to be an independent prognostic factor of PFS and OS for patients with metastatic ccRCC after surgery, and it can be utilized to enhance the predictive ability of well-established prognostic models.